Tangelder, Marco
UniQure (Netherlands)
3 papers on CoChat
Most cited papers
- Verified
Gene Therapy With Adeno-Associated Virus Vector 5-Human Factor IX in Adults With Hemophilia B
Miesbach, W., Meijer, K., Coppens, M., Kampmann, P., Klamroth, R., Schutgens, R., Tangelder, M., Castaman, G., Schwäble, J., Bonig, H., et al. (2018) · Blood
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 301
- Verified
The long-term prognostic value of the resting and postexercise ankle–brachial index
Feringa, H. H. H., Bax, J. J. J., van Waning, V. H., Boersma, E., Elhendy, A., Schouten, O., Tangelder, M. J., van Sambeek, M. H. R. M., van den Meiracker, A. H., & Poldermans, D. (2006) · Archives of Internal Medicine
Peripheral Artery Disease ManagementCardiovascular Health and Disease Prevention
Cited by 141
- Verified
Therapeutic hFIX activity achieved after single AAV5-hFIX treatment in hemophilia b patients and NHPs with pre-existing anti-AAV5 NABs
Majowicz, A., Nijmeijer, B., Lampen, M. H., Spronck, L., de Haan, M., Petry, H., van Deventer, S. J., Meyer, C., Tangelder, M., & Ferreira, V. (2019) · Molecular Therapy - Methods & Clinical Development
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 126
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free